European Cancer Organisation

Value Based Healthcare

Value Based Healthcare

Linking from ECCO's recent access to innovation position paper and its advocacy for refinement to the way in which value assessments are made about innovation, an ECCO-led project to investigate how value assessment methodologies might be applied to non-systemic oncology treatment has now commenced.

ESTRO President Professor Yolande Lievens leads the group. Other participants in the group include: Elizabeth De Vries, a medical oncologist involved in the development of the ESMO magnitude of benefit scale; Riccardo Audisio of ESSO and Ian Banks of the ECCO Patient Advisory Committee (ECCO PAC).

The project will be rolled out in two phases:

  • Phase 1 of the project will identify what methodologies for determining value of innovation in healthcare presently exist, critically evaluate these and make reflection as to their potential adapted application to non-systemic oncology treatment, by way of a published paper. 
  • Phase 2 of the project is intended to draw in the views of a wider range of stakeholders on the early conclusions formed in phase 1 with reporting on the prospects or not of a modified tool for establishing value in non-systemic oncology treatment innovations in time for the ECCO 2018 European Cancer Summit
Page last modified: